Live Versus Inactivated Influenza Vaccine Study in Hutterite Children

PHASE4CompletedINTERVENTIONAL
Enrollment

4,611

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent Inactivated Vaccine

Influenza vaccination, 0.5 ml dose administered intramuscularly. Previously unvaccinated children who are less than 9 years of age at the time of immunization will receive a second 0.5 ml dose four weeks later.

BIOLOGICAL

Live Attenuated Influenza Vaccine

Influenza vaccination, 0.2 ml dose administered intranasally. Previously unvaccinated children who are less than 9 years of age at the time of immunization will receive a second 0.2 ml dose of the vaccine four weeks later.

Trial Locations (1)

L8S 4K1

McMaster University, Hamilton

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McMaster University

OTHER

NCT01653015 - Live Versus Inactivated Influenza Vaccine Study in Hutterite Children | Biotech Hunter | Biotech Hunter